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Abstract
Background:  SSeCKS (Src  SupprEssed  C Kinase  Substrate) is a proposed protein kinase C
substrate/A kinase anchoring protein (AKAP) that has recently been characterized in the rat
peripheral nervous system. It has been shown that approximately 40% of small primary sensory
neurons contain SSeCKS-immunoreactivity in a population largely separate from substance P
(95.2%), calcitonin gene related peptide (95.3%), or fluoride resistant acid phosphatase (55.0%)
labeled cells. In the spinal cord, it was found that SSeCKS-immunoreactive axon collaterals
terminate in the dorsal third of lamina II outer in a region similar to that of unmyelinated C-, or
small diameter myelinated Aδ-, fibers. However, the precise characterization of the anatomical
profile of the primary sensory neurons containing SSeCKS remains to be determined. Here,
immunohistochemical labeling at the light and ultrastructural level is used to clarify the myelination
status of SSeCKS-containing sensory neuron axons and to further clarify the morphometric, and
provide insight into the functional, classification of SSeCKS-IR sensory neurons.
Methods: Colocalization studies of SSeCKS with myelination markers, ultrastructural localization
of SSeCKS labeling and ablation of largely unmyelinated sensory fibers by neonatal capsaicin
administration were all used to establish whether SSeCKS containing sensory neurons represent a
subpopulation of unmyelinated primary sensory C-fibers.
Results: Double labeling studies of SSeCKS with CNPase in the dorsal horn and Pzero in the
periphery showed that SSeCKS immunoreactivity was observed predominantly in association with
unmyelinated primary sensory fibers. At the ultrastructural level, SSeCKS immunoreactivity was
most commonly associated with axonal membrane margins of unmyelinated fibers. In capsaicin
treated rats, SSeCKS immunoreactivity was essentially obliterated in the dorsal horn while in dorsal
root ganglia quantitative analysis revealed a 43% reduction in the number of SSeCKS-labeled cells.
This attenuation is concomitant with a decrease in fluoride-resistant acid phosphatase labeled fibers
in the spinal cord dorsal horn and small neuronal somata in sensory ganglia.
Conclusion:  These results demonstrate that SSeCKS is primarily localized within a distinct
subpopulation of small diameter, largely unmyelinated C-fiber primary sensory neurons putatively
involved in nociception.
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Background
A kinase anchoring proteins (AKAPs) are a family of pro-
teins necessary for cellular organization and compartmen-
talization and, as such, are likely integral components of
intracellular signaling pathways [1-5]. One such AKAP,
Src-suppressed C Kinase Substrate (SSeCKS), is accepted
as the rodent orthologue (69% homology) of the primate
specific protein gravin [6]. Gravin is expressed in an exten-
sive array of tissue including fibroblasts, vascular
endothelium, neural crest derived cells, and portions of
the central (cerebellum) and peripheral (peripheral nerve,
myenteric plexus and satellite cells) nervous systems [7]
SSeCKS (previously identified as clone 72, [8]) has been
characterized as a substrate of PKC, PKA or rho family
members [9-11]. In both fibroblasts and vascular smooth
muscle cells, SSeCKS has been implicated in actin-medi-
ated cytoskeletal plasticity [12,10] that may impact cell
growth, spread and adhesion [13,10,14,15,11,16]. Within
the nervous system, the distribution of SSeCKS has been
described [17], but the role of SSeCKS remains unre-
solved.
In the rodent nervous system, SSeCKS-IR has been dem-
onstrated within rat cerebellum, the dorsal horn at all ros-
trocaudal spinal levels, sensory ganglia (including spinal
trigeminal ganglia) and the mesencephalic nucleus of the
trigeminal nerve [17]. In the dorsal root ganglia, SSeCKS-
IR was localized within the cytoplasm of a specific sub-
population of small diameter neuronal perikarya. Simul-
taneous double labeling with classic neurochemical
markers indicated that SSeCKS is found in cells that infre-
quently contain substance P (4.8%; SP) or calcitonin
gene-related peptide (4.7%; CGRP) but more often (45%)
express fluoride-resistant acid phosphatase (FRAP). In the
dorsal horn of the spinal cord, double labeling for SSeCKS
and acid phosphatase revealed that SSeCKS-IR fibers are
localized to laminar levels dorsal to the dorsal-most third
of lamina II outer. These results imply that SSeCKS may be
localized within a neurochemically distinct subpopula-
tion of C- or Aδ-fiber afferents.
In light of the uncertainty regarding the class of primary
sensory neuron that contains SSeCKS, determination of
the myelination status of SSeCKS-IR neurons would pro-
vide insight into the fiber classification. However,
ultrastructural examination of SSeCKS containing somata
or central and peripheral axonal arborizations has not
been conducted. Examination of SSeCKS-IR neurons at
the ultrastructural level would have implications regard-
ing not only the myelination status, diameter and,
through inference, the modality responsiveness of
SSeCKS-containing primary sensory axons but also the
subcellular coincidence between SSeCKS and the known
distribution of PKA or components of AKAP related sign-
aling cascade.
Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is an irri-
tant extracted from chili peppers (Capsicum annum) that,
following systemic injection into neonatal rats, causes
extensive diminution in the number of unmyelinated fib-
ers (approximately 50% in adults) with minimal impact
on the number of thinly myelinated fibers [18-21]. Func-
tionally, the unmyelinated C-fibers that persist following
neonatal capsaicin administration may represent low-
and high-threshold mechanoreceptors and cold receptors
[22,23]. This implies that the lesioned fibers represented
chemoreceptors, heat sensitive thermoreceptors and pos-
sibly polymodal nociceptors. The effect of capsaicin is
dose-dependent such that amounts much greater than 50
mg/kg almost completely obliterate unmyelinated pri-
mary sensory fibers (94%) while also eliminating small
myelinated fibers by 40% [20]. At doses normally
employed, neonatal capsaicin application selectively
reduces the number of cells containing markers of small
diameter sensory neurons such as SP, CGRP or FRAP and
those cells expressing the putative capsaicin receptor,
vanilloid receptor subtype-1 (VR-1). For example, the
number of FRAP-containing dorsal root ganglion (DRG)
neurons is decreased by approximately 65% [24,25] and
the distribution of FRAP-containing terminals in the dor-
sal horn is almost completely attenuated. The number of
primary sensory somata containing SP is reduced by
approximately 90% [21] while those that contain CGRP
are reduced by approximately 50–60% [26]. Not surpris-
ingly, the number of neurons destroyed by capsaicin is
similar to the number that contains the capsaicin receptor,
VR-1 [27-29]. In light of the demonstrated specificity of
neonatal capsaicin administration for unmyelinated pri-
mary afferents, this agent is a useful tool for the selective
ablation of C-fibers.
Given that our previous study raised the possibility, but
did not demonstrate, that SSeCKS primary sensory neu-
rons are largely unmyelinated C-fibers, the neonatal cap-
saicin model and ultrastructural localization of SSeCKS is
employed here to further investigate and clarify the func-
tional and morphological identification of SSeCKS-IR
neurons. A portion of these results has been reported in
abstract form [30].
Methods
A total of 19 Sprague-Dawley rats, of either gender, were
used in this report. All procedures adhered to the appro-
priate animal care guidelines of the University of North
Dakota and the National Institutes of Health.
Capsaicin-induced attenuation of SSeCKS labeling
For the capsaicin study, four littermate pups (2 male; 2
female; postnatal day 5; approximately 12.5 g body
weight) received an intraperitoneal injection of 50 mg/kg
capsaicin (8-methyl-N-vanillyl-nonenamide, Sigma) in 0.9%Journal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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saline with 50% ethanol. Control animals consisted of
two littermates (1 male, 1 female) injected with pseudo-
capsaicin (postnatal day 5; 50 mg/kg;N-vanillylnonana-
mide, Sigma) in 0.9% saline with 50% ethanol and two
un-injected littermates (both male). Pseudocapsaicin-
injected animals served as controls for both the injection
vehicle and nonspecific actions of capsaicin-like ana-
logues. All control and capsaicin injected animals were
housed together.
Animals from the capsaicin study (capsaicin-injected,
pseudocapsaicin-injected, and control) were euthanized
with pentobarbitol at 10 weeks of age and were perfused
transcardially with 100 ml of cold (4°C) 0.9% saline con-
taining 0.1% sodium nitrite and 0.01% heparin followed
by 400 ml of cold freshly prepared fixative consisting of
4% paraformaldehyde and 0.16% para-picric acid in 0.1
M sodium phosphate buffer, pH 7.4. The spinal cord and
dorsal root ganglia were removed immediately after per-
fusion and placed in a cold postfixative for 2 h followed
by cryoprotection for at least 48 hrs in cold (4°C) 25%
sucrose and 10% glycerol in 50 mM phosphate buffer.
Sensory ganglia and segmental blocks of lumbar spinal
cord were fast frozen in O.C.T. embedding compound
(Tissue-Tek) and cut using a cryostat at 20 µm (ganglia) or
30 µm (spinal cord) and collected into 0.1 M sodium
phosphate buffer (pH 7.4) containing 0.9% saline (PBS).
As described below, sections of sensory ganglia and spinal
cord were then processed for SSeCKS immunolabeling
alone or simultaneously double labeled for SSeCKS and
VR-1. Sections of sensory ganglia and lumbar spinal cord
were processed separately for FRAP enzyme histochemis-
try.
Sections of spinal cord or ganglia were incubated for 40–
68 h at 4°C in a 1:100 dilution (in PBS containing 0.3%
Triton-X; PBS-T) of anti-SSeCKS mouse monoclonal anti-
body (BD Transduction Labs). Labeling produced by this
antibody in the rat nervous system has been previously
described and characterized [17]. Following primary incu-
bation, sections were washed twice in PBS-T, incubated
1.5 hours at room temperature with CY3-conjugated don-
key anti-mouse antibody IgG (Jackson ImmunoResearch)
at a dilution of 1:100 in PBS-T, then washed again in PBS-
T followed by 50 mM Tris-HCl. All washes were 20 min-
utes. Tissue sections were mounted onto gel coated slides
using 50 mM Tris HCl (pH 7.4) and coverslipped with
VectaShield (Vector) anti-fade mounting medium.
Double-immunofluorescence labeling was conducted on
sections from spinal ganglia and lumbar spinal cord. Sec-
tions were simultaneously incubated with SSeCKS and
guinea pig polyclonal VR-1 (1:1,000; Chemicon) fol-
lowed by two washes in PBS-T and incubated in CY3-con-
jugated donkey anti-mouse (as above) and FITC-
conjugated donkey anti-guinea pig (1:100; Jackson
ImmunoResearch) secondary antibodies.
FRAP enzyme histochemical procedures were conducted
on sections of spinal ganglia and lumbar spinal cord as
previously described [25]. Sections were first washed in 20
mM Tris-maleate (pH 5.0) for 30–60 min then reacted
overnight at room temperature in a solution of filtered 6.9
mM β-glycerophosphate disodium salt hydrate, 0.9 mM
lead (II) nitrate, and 0.25 µM sodium fluoride in 20 mM
Tris-maleate. Sections were then visualized by a brief
immersion in 2% ammonium sulfide, mounted onto
glass slides from 50 mM Tris HCl (pH 7.4), and cover-
slipped with 9:1 glycerol: water.
Sections reacted for FRAP were analyzed using brightfield
microscopy while all other immunolabeled sections were
analyzed using incidental fluorescence (Olympus BX-60
or BX-50). Video images were captured using a Dage-MTI
CCD-300-RC camera (at 8 bits per pixel) and Flashpoint
framegrabber or a v 3.45 SPOT-RT slider digital camera
(Diagnostic Instruments, Inc.). FRAP reacted sections of
the lumbar spinal cord and DRG were analyzed to deter-
mine efficacy of the capsaicin treatment. Data collection
for SSeCKS-IR DRG cells and for FRAP-reacted cells from
both control and capsaicin-treated animals were con-
ducted by microscopic analysis. Data from multiple ani-
mals were combined after determination that the
variation and distribution were not significantly different
and that the samples did not represent statistically differ-
ent populations (Kolmogorov-Smirnov for normality test-
ing and Levene median for tests of equal variance).
Statistical analysis of the data from all eight animals in the
capsaicin study was conducted using SigmaStat (Jandel).
Relationship of SSeCKS with markers of myelination
Three adult Sprague-Dawley rats were perfused with 4%
paraformaldehyde with picric acid fixative as described
above. Sections of spinal cord, dorsal root ganglia, sciatic
nerve and glabrous tissue were then processed for SSeCKS
and CNPase, or Pzero double immunohistochemical
labeling. Sections were simultaneously incubated with a
sheep polyclonal SSeCKS (1:200; Exalpha) and either
Pzero (1:200; Neuromics) or CNPase (1:200;Chemicon)
primary antibodies followed by two washes in PBS-T and
incubation in CY3-conjugated donkey anti-sheep (1:100;
Jackson ImmunoResearch; for SSeCKS labeling) and fluo-
rescein isothiocyanate (FITC)-conjugated donkey anti-
chicken (1:100; Jackson ImmunoResearch; for Pzero labe-
ling) or FITC-conjugated donkey anti-mouse (1:100; Jack-
son ImmunoResearch; for CNPase labeling) secondary
antibodies. Sections were then washed in PBS-T followed
by 50 mM Tris-HCl and mounted onto gel-coated slides
using 50 mM Tris HCl (pH 7.4) and coverslipped withJournal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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VectaShield (Vector) anti-fade mounting medium. All
antibodies used in this study were well characterized and
commercially available. In addition, the Exalpha SSeCKS
antibody has been further characterized [17] by our lab.
Omission of primary and secondary antibodies did not
reveal non-specific labeling or evidence of cross-reactivity.
Analysis of labeling was conducted as described above.
Analysis of colocalization (double-labeling) was con-
ducted using photomontages of high magnification
images in order to maximize resolution. All images were
obtained using filter cubes optimized for CY3 (excitation
filter BP 520–550; dichroic beamsplitter DM 565; band-
pass barrier filter BA 580 IF) or FITC (excitation filter BP
460–490; dichroic beamsplitter DM 500; bandpass bar-
rier filter BA 515–550 IF) in order to minimize dye cross
talk or bleed-through. Confocal microscopic analysis was
performed using an Olympus IX70 microscope with a
Fluoview 300 PMT (Olympus) and Fluoview software
(Olympus).
Ultrastructural localization of SSeCKS
Perfusion of eight adult Sprague-Dawley rats for electron
microscopy was performed as described above except with
4% paraformaldehyde/0.5% glutaraldehyde fixative. Egg
imbedded tissue was sectioned (50 µm) on a Series 1000
Vibratome and incubated for 48 h at 4°C with a mouse
monoclonal SSeCKS (1:100; BD Transduction Labs) anti-
body. Sections were washed for 40 min in PBS-T and then
incubated for 1.5 with biotinylated rabbit anti-goat IgG
(ABC kit, Vector) followed by avidin-biotin complex incu-
bation for 1.5 h (ABC kit, Vector). Binding of the ABC rea-
gent was visualized using a glucose oxidase/
diaminobenzidine method (DAB; Sigma). In order to
enhance labeling, glucose oxidase and nickel ammonium
sulfate-intensified diaminobenzidine (GDN) were uti-
lized. Following osmication and dehydration, the tissue
was infiltrated with Durcupan and then coverslipped
overnight. These sections were then mounted on Epon
blocks and sectioned at ~70 nm on a RMC MTX ultrami-
crotome equipped with a Diatome diamond knife and
placed on copper grids. Following staining with 2% ura-
nyl acetate and lead citrate for 5 minutes each, these grids
were washed and allowed to dry overnight. Prepared grids
were then analyzed on a Hitachi H-7500 transmission
electron microscope (TEM).
Results
Minimal colocalization was observed between SSeCKS-
and CNPase-immunoreactivity (-IR) in the lumbar dorsal
horn, Lissauer's tract, and lamina X (Fig. 1A). This was
confirmed using confocal microscopy, which revealed
minimal colocalization between SSeCKS and CNPase
except for the occasional double-labeled puncta observed
in laminae ventral to the substantia gelatinosa. The
CNPase labeling was primarily restricted to oligodendro-
cytes in deeper laminae while SSeCKS was located in Lam-
ina I and II outer. Although both SSeCKS and CNPase
labeling are found in Lissauer's tract and lamina X, double
labeled fibers were not apparent.
In the dorsal root ganglion, Pzero (Schwann cell marker)
labeling could be observed in association with axons that
appeared to be arising from neuronal somata (Fig. 1B).
However, none of the fibers with associated Pzero labe-
ling appeared SSeCKS-immunoreactive. In peripheral
nerve, colocalization of SSeCKS-labeled fibers and those
associated with Pzero immunoreactivity (Fig. 1C) could
not be established. However, in glabrous skin from the
hindpaw, colocalization of Pzero and SSeCKS was
observed toward peripheral axon terminals (Fig. 1D) and
in the immediate vicinity of Meissner's corpuscles (not
shown).
At the ultrastructural level, SSeCKS labeling was observed
in the outer laminae of the lumbar dorsal horn (Fig. 2A).
Specifically, SSeCKS-IR was associated with small diame-
ter processes aggregated between larger diameter, myeli-
nated axons. Occasionally, SSeCKS-IR could be seen
within the cytoplasm of thinly myelinated axons (Fig.
2B). Comparison revealed these axons to be substantially
smaller in diameter than those SSeCKS-negative axons
with heavy myelination. Of the SSeCKS labeled cross-sec-
tional profiles quantified, 15% appeared myelinated
(1484 profiles counted). In those areas of the dorsal horn
(ventral to lamina II) in which small diameter myelinated
fibers were more abundant, myelinated SSeCKS labeled
fibers were more commonly observed than non-myeli-
nated SSeCKS labeled profiles. At the subcellular level,
SSeCKS-IR was consistently localized to the plasma mem-
brane and was frequently observed as a granular deposi-
tion throughout axonal cytoplasm (Fig. 2C, enlargement).
Occasional labeling of membrane-associated vesicles was
also detected. SSeCKS-IR was not found in association
with any glial profiles but was found in endothelial cells
as had been previously reported [12].
Qualitative evaluation of the efficacy of the capsaicin
administration was undertaken by comparative examina-
tion of FRAP and VR-1 labeling (Fig. 3) in sections of L4
spinal ganglia and transverse sections of L4 spinal cord
from un-injected control, pseudocapsaicin-injected con-
trol and capsaicin injected animals. Pseudocapsaicin-
injected and un-injected controls were comparable by all
assessments. In comparison with control animals, capsai-
cin-injected animals demonstrated a considerable in the
number of FRAP labeled small primary sensory neuron
somata and central axonal collaterals (Fig. 3A, B). The
robust and abundant FRAP labeling observed in small
diameter primary sensory somata from control animalsJournal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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Micrographs depicting SSeCKS colocalization with myelination markers (CNPase and Pzero) Figure 1
Micrographs depicting SSeCKS colocalization with myelination markers (CNPase and Pzero). (A) SSeCKS (red) 
and CNPase (green) in the lumbar spinal cord dorsal horn. The labeling appears discrete with minimal colocalization. (B) 
SSeCKS (red) and Pzero (green) in the L4 dorsal root ganglia. A lack of co-localization is observed and Pzero can be seen local-
ized to putative axonal elements (arrow). (C) SSeCKS (red) and Pzero (green) in the sciatic nerve. As in the dorsal root ganglia, 
a lack of co-localization is observed. Both SSeCKS and Pzero can be seen localized to axonal elements. (D) SSeCKS (red) and 
Pzero (green) in glabrous skin of the hind-paw, fibers displaying colocalization (yellow) can be observed (arrow).Journal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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Electron micrographs of SSeCKS-IR in the lumbar spinal cord dorsal horn Figure 2
Electron micrographs of SSeCKS-IR in the lumbar spinal cord dorsal horn. (A) SSeCKS labeling in the dorsal horn of 
the spinal cord demonstrating the zone within lamina II outer in which the band of SSeCKS labeling (upper left of micrograph) 
is separated (dashed line) from the area of the dorsal horn lacking SSeCKS labeling (lower right of micrograph). (B) SSeCKS 
labeling of thinly myelinated fibers (arrows) located next to larger diameter, more heavily myelinated axons lacking SSeCKS 
labeling. (C) SSeCKS labeling of a bundle of unmyelinated fibers. (D) Enlargement of portion of (C) reveals labeling around the 
axonal plasma membrane (black arrow) of individual unmyelinated fibers, as well as labeling around vesicular structures (white 
arrow).Journal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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(Fig. 3A) was in marked contrast to the relatively limited
number of small cells, either unlabeled or containing
FRAP reaction product, observed in sections of DRG from
capsaicin injected animals (Fig. 3B). In the dorsal horn,
the intense band of FRAP reaction product in control ani-
mals (Fig. 3A inset) was almost entirely obliterated in ani-
mals treated neonatally with capsaicin (Fig. 3B inset).
As with FRAP reaction product, VR-1 labeling was sub-
stantially reduced in sections of both spinal ganglia and
lumbar spinal cord (Fig. 3C,D). In sections of L4 DRG, the
abundant VR-1 labeled primary sensory somata seen in
control animals (Fig. 3C) were almost entirely depleted in
capsaicin-injected animals (Fig. 3D). Likewise, in the dor-
sal horn, VR-1-immunofluorescence observed in the
superficial lamina of the dorsal horn of control animals
Micrographs demonstrating capsaicin-mediated depletion of a population of primary sensory neurons Figure 3
Micrographs demonstrating capsaicin-mediated depletion of a population of primary sensory neurons. (A) 
FRAP enzyme histochemical reaction product in a section of L4 DRG from a control animal. FRAP reaction product was 
present within approximately 40% of the small diameter cell bodies. (B) FRAP enzyme histochemical reaction product in a sec-
tion of L4 DRG from a capsaicin treated animal. The number of somata containing FRAP reaction product was greatly dimin-
ished compared to untreated animals (A). (Insets A, B) FRAP enzyme histochemical reaction in transverse sections of L4 spinal 
cord dorsal horn from control (Inset A) and capsaicin (Inset B) animals. FRAP reaction product was localized within the dorsal 
third of lamina II of the dorsal horn in control animals and comparatively reduced in capsaicin treated animals. Dorsal is to top. 
(C) VR-1-immunofluorescence in a section of L4 DRG from a control animal. (D) VR-1-immunofluorescence in a section of L4 
DRG from a capsaicin treated animal. The number of somata containing VR-1-immunofluorescence is greatly diminished com-
pared to untreated animals (A). (Insets C, D) VR-1-immunofluorescence in transverse sections of L4 spinal cord dorsal horn 
from control (Inset C) and capsaicin (Inset D) animals. VR-1 staining was almost completely eliminated following capsaicin 
treatment.Journal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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(Fig. 3C inset) was almost entirely ablated in capsaicin-
injected (Fig. 3D inset) animals.
Quantitative evaluation of the efficacy of the capsaicin
administration was undertaken by comparative analysis
of the number of FRAP-labeled somata in control, com-
pared to capsaicin-injected, animals. In control animals, a
mean of 40.2% (± 4.4 S.D.; 7,877 cells counted from 4
animals) of DRG cells contained FRAP-enzyme reaction
product whereas a mean of 25.1% (± 5.8 S.D.; 5,258 cells
counted from 4 animals) DRG cells contained FRAP reac-
tivity in animals receiving neonatal capsaicin treatment.
Statistical analysis of counts was performed using a t-test
to determine whether results from individual animals
could be binned into groups. Counts from individual con-
trol animals were found to be not statistically different (p
= 0.066) and therefore sample sets from all control ani-
mals were grouped. Likewise, counts from individual cap-
saicin-injected animals were also found to be statistically
similar (p = 0.235) and therefore sample sets from all cap-
saicin-injected animals were grouped. Differences
between the number of FRAP-labeled somata in sections
of L4 DRG from control and capsaicin-injected animals
were compared using an unpaired t-test. Capsaicin-treated
animals were found to have significantly (p < 0.001) fewer
FRAP-labeled primary sensory somata versus control ani-
mals.
The effect of neonatal capsaicin administration on
SSeCKS-IR in adult animals was examined in both trans-
verse spinal cord and sensory ganglia sections. In control
animals, SSeCKS-IR was similar to that previously
reported [17]. In brief, SSeCKS-IR was observed in puta-
tive primary afferent central axonal arbors in Lissauer's
tract, lamina I and II, as well as in occasional fibers seen
to course ventrally into lamina III and IV. In addition, ros-
trocaudally oriented SSeCKS-IR fibers were observed both
dorsal and ventral to the central canal (lamina X; Fig. 4A
inset). Conversely, capsaicin-treated animals demon-
strated a distinct diminution of SSeCKS-IR (Fig. 4B). The
entire first and second lamina was devoid of SSeCKS-IR
fibers with the rare exception of occasional faint, large
diameter fibers traversing dorsoventrally through the
superficial lamina. In addition, a reduction in SSeCKS-IR
was observed in the area dorsal and ventral to the central
canal (lamina X) of the spinal cord (Fig. 4B inset). In the
dorsal columns (not shown) of capsaicin-injected ani-
mals some SSeCKS-IR persisted in apparent massed bun-
dles of axonal processes.
In sections of spinal ganglia from control animals,
SSeCKS-IR was distributed throughout the cytoplasm of
sensory neuron somata with an area of increased perinu-
clear intensity present in most perikarya (Fig. 4C). Not-
withstanding the degree of cytoplasmic labeling, intense
SSeCKS-IR was often observed distributed along the
somatic plasma membrane of sensory neurons of all
diameters. Nuclei did not display SSeCKS-IR in any of the
observed cell types. As previously reported, most cytoplas-
mic labeling was restricted to small diameter sensory neu-
rons with rare large cells displaying low levels of
cytoplasmically distributed SSeCKS-IR. Sections of sen-
sory ganglia from capsaicin-treated animals revealed a
considerable overall decrease in SSeCKS-IR. Most notably
reduced was the number of small diameter primary sen-
sory perikarya containing cytoplasmic SSeCKS-IR (Fig.
4D). The SSeCKS-IR that persisted in capsaicin-injected
animals was not of apparent qualitative difference in
localization.
Quantitative analysis from sections of L4 ganglia revealed
a significant (p < 0.05; one-way ANOVA; Dunnett's post-
hoc test) 42.5% reduction in the number of SSeCKS-
labeled cells in capsaicin-treated, as compared to control,
animals. In capsaicin-treated tissue, a mean of 16.9% (±
5.3 S.D.; 6,398 cells counted from 4 animals) of small
cells contained SSeCKS-IR while in control tissue, a mean
of 29.4% (± 5.7 S.D.; 3,903 cells counted from 4 animals)
small cells were SSeCKS-IR.
Discussion
Evaluation of colocalization between SSeCKS and CNPase
at both the fluorescence and confocal microscope level
suggests myelinated axons in the dorsal horn of the spinal
cord contain minimal SSeCKS-IR. This finding is in agree-
ment with our failure to find co-localization between
SSeCKS and Pzero in the sciatic nerve and dorsal root gan-
glia. In glabrous skin, however, fluorescence and confocal
microscopy revealed a colocalization of SSeCKS and Pzero
in axons immediately proximal to peripheral nerve termi-
nals. This may suggest that SSeCKS is localized in the dis-
tal-most terminations of myelinated fibers. Interestingly,
Meissner's corpuscles from glabrous skin appeared inner-
vated by axons immunoreactive for both SSeCKS and
CGRP suggesting that SSeCKS may be associated with
neurons that convey light touch, in addition to those con-
veying nociceptive signals. This observation, along with
previously demonstrated innervation of Meissner's cor-
puscles by small, SP- or CGRP-IR fibers [31] suggests that
signals from these sensory transducers may be modified
by nociceptor axons.
At the ultrastructural level, the demonstration of SSeCKS
labeling in bundled unmyelinated axons in dorsal horn
outer laminae suggests that SSeCKS is associated with C-
fibers central arborizations. However, the presence of
SSeCKS-IR in occasional thinly myelinated, small diame-
ter axons indicates that SSeCKS is not exclusively con-
tained in C-fibers and may also be associated with a small
number of A-delta fibers. The prevalence of SSeCKS-Journal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
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labeled unmyelinated fibers in certain areas suggests they
are region-specific. In conjunction with CNPase-IR dis-
playing minimal colocalization with SSeCKS in laminae
ventral to the substantia gelatinosa, this data showing
regions of SSeCKS labeled myelinated fibers in C-fiber
sparse areas suggests they are located in laminae outside
the substantia gelatinosa, possibly in more ventral lami-
nae.
The subcellular localization of SSeCKS to the plasma
membrane is consistent with that described for other
AKAPS possessing a membrane-binding domain. This
suggests that SSeCKS, like certain other AKAPs, may have
a role at the axonal membrane [1,4]. This role may involve
PKA-mediated intracellular signaling, possibly through
adrenergic or prostaglandin receptors, similar to that
reported for the human SSeCKS homologue gravin [2,3].
These ultrastructural results, in combination with the
myelination status results (CNPase and Pzero) described
above, strongly suggest that SSeCKS is only occasionally
associated with myelinated central or peripheral primary
sensory axons.
Micrographs showing SSeCKS-immunoreacted sections of L4 DRG and spinal cord superficial dorsal horn from control and  capsaicin-treated rats Figure 4
Micrographs showing SSeCKS-immunoreacted sections of L4 DRG and spinal cord superficial dorsal horn 
from control and capsaicin-treated rats. (A) In control animals, robust SSeCKS-immunofluorescence is present within 
Lissauer's tract (LT) and lamina I, II and dorsal lamina III. In the same section of lumbar spinal cord, brightly labeled, rostrocau-
dally oriented axon bundles are observed ventral to the central canal (Inset A). (B) In capsaicin-injected animals, SSeCKS-
immunofluorescence within Lissauer's tract and lamina I, II and III is depleted. In the same section, the intensity and abundance 
of SSeCKS-labeled axons ventral to the central canal is greatly reduced (Inset B). (C) In ganglia sections from control animals, 
SSeCKS immunolabeling can be observed in the cytoplasm of small cells and associated with the perimeter of both small and 
large cells. (D) In ganglia sections from capsaicin-injected animals, a decrease in the number of small cells was quantified along 
with a corresponding lack of SSeCKS immunolabeling in the cytoplasm of small cells.Journal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:8 http://www.jbppni.com/content/3/1/8
Page 10 of 11
(page number not for citation purposes)
FRAP and VR-1 labeling were employed to establish the
effectiveness of the neonatal capsaicin treatment. A quan-
titative assessment of capsaicin effectiveness, using well-
established methods, was essential prior to determining
its effect on SSeCKS labeling. Previous studies analyzing
the effectiveness of capsaicin have traditionally used FRAP
enzyme histochemistry as a marker of neuronal loss
[25,32,33]. Although FRAP was used here, reports of the
extensive colocalization of Griffonia simplicifolia isolectin
I-B4 with FRAP [34] and LA4 with FRAP [35] suggest that
SSeCKS/FRAP containing primary afferent neurons are
also likely reflective of both SSeCKS/I-B4 and SSeCKS/LA4
subpopulations. Capsaicin treatment has been previously
demonstrated to reduce the number of FRAP reactive
somata in spinal ganglia by approximately 50%
[25,32,33] although the degree of attenuation is depend-
ent on many factors (e.g. dose, administration, concentra-
tion) [20]. The loss of VR1 and FRAP labeling in both
DRG and spinal cord suggests that neonatal capsaicin
administration was effective at eradicating a specific sub-
population of primary sensory neurons, composed of
unmyelinated C-fibers and a variable degree of small-
diameter myelinated (Aδ) fibers.
We previously demonstrated [17] that SSeCKS-IR is pre-
dominantly localized within small, type B somata within
sensory ganglia. The large, capsaicin-induced reduction
(43%) in SSeCKS labeled cells confirms that SSeCKS is at
least partially localized to the unmyelinated, or small
myelinated capsaicin-sensitive primary sensory neuron
population. Of the SSeCKS-IR somata that persist, the pat-
tern of intense, diffuse cytoplasmic immunoreactivity
appeared similar to that observed in untreated animals.
In capsaicin treated animals, the spinal cord superficial
dorsal horn, at all segmental levels, was almost com-
pletely devoid of SSeCKS immunofluorescence. The
number and/or intensity of SSeCKS-IR peri-central canal
fibers were also substantially diminished in capsaicin-
treated animals. These findings, along with the absence of
SSeCKS-IR somata within the CNS, suggest that SSeCKS-
IR axons seen in the spinal cord of control animals repre-
sent the central termination of C-fiber or Aδ primary sen-
sory neurons rather than axon terminals of descending or
intrinsic spinal neurons.
Preservation of a subpopulation of SSeCKS-IR somata in
the sensory ganglia with a corresponding complete loss of
SSeCKS-IR fibers in the dorsal horn following neonatal
capsaicin exposure suggests that those somata ablated by
capsaicin represent the ganglionic component of the
intensely labeled axons terminating in the dorsal horn of
the spinal cord. Those SSeCKS-IR somata that persist fol-
lowing capsaicin treatment may contribute to the very
light SSeCKS immunoreactive fibers previously reported
to penetrate more ventral lamina [17].
Furthermore, the capsaicin results, taken together with the
ultrastructural data revealing most SSeCKS-IR fibers to be
non-myelinated, suggest that the observed SSeCKS immu-
noreactivity ablation was due largely to C-fiber destruc-
tion with a lesser involvement of small myelinated fibers.
Conclusion
In light of the findings reported here, we propose that
SSeCKS-IR within the peripheral nervous system is local-
ized within a subpopulation of neurochemically distinct
C-fibers and occasional thinly myelinated Aδ-fiber affer-
ents. The myelination status and neurochemical profile of
SSeCKS-IR fibers suggests that they likely convey nocicep-
tive, thermal, or crude touch modalities and, furthermore,
the presence of SSeCKS-IR fibers in the glabrous footpad
is indicative of a superficial nociceptive capability. In as
much as SSeCKS is an AKAP, its involvement in PKA mod-
ulated hypersensitivity is plausible and remains to be
determined.
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